Author

Deepak Kumar Mishra

Nationwide Children's Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Assay:DNA methylation· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Banlanjo Abdulaziz UmaruiD· 2 shared Rachid DrissiiD· 2 shared Shiva Senthil KumariD· 2 shared Andrew BondociD· 1 shared Annie HuangiD· 1 shared Augusto Faria AndradeiD· 1 shared Brendan Devine· 1 shared Caterina RussoiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Banlanjo Abdulaziz UmaruORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BMI-1 Modulation and Trafficking During M Phase in Diffuse Intrinsic Pontine Glioma

Banlanjo Abdulaziz Umaru, Deepak Kumar Mishra, Shiva Senthil Kumar, Hao‐Han Pang, Brendan Devine, Komal Khan, Rachid Drissi

This study shows BMI-1 phosphorylation in DIPG cells during M phase leads to cytoplasmic translocation via CRM1-mediated nuclear export.

FEBS Open Bio · Dec 27, 2025Peer-reviewedCancer Biology

Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain Tumors

Deepak Kumar Mishra, Shelli M. Morris, Dean Popovski, Emily J. Girard, Andrew Bondoc, Shiva Senthil Kumar, Augusto Faria Andrade, Xiaoting Zhu, Fupan Yao, Mi‐Youn Brusniak, Banlanjo Abdulaziz Umaru, Erin E. Crotty, Kenneth Brasel, Fiona J. Pakiam, Caterina Russo, , Rachid Drissi

This study investigates the combination of DNA methyltransferase inhibitor decitabine and PD-1 inhibitor in high-risk pediatric brain tumor models, finding improved survival in some subtypes.

bioRxiv · May 14, 2025 · PreprintImmunology